Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02105233Phase 1Completed
Phase 1, open-label, single-arm trial of acoustic coupling fluid in glioblastoma (GBM), sponsored by St. Olavs University Hospital. Primary endpoint: Adverse Events at 6 months. Started Feb 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02105233.